BrainsWay Statistics
Total Valuation
BrainsWay has a market cap or net worth of $567.91 million. The enterprise value is $511.68 million.
| Market Cap | 567.91M |
| Enterprise Value | 511.68M |
Important Dates
The last earnings date was Wednesday, May 13, 2026, before market open.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BrainsWay has 38.17 million shares outstanding. The number of shares has increased by 3.85% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 38.17M |
| Shares Change (YoY) | +3.85% |
| Shares Change (QoQ) | -8.91% |
| Owned by Insiders (%) | 17.04% |
| Owned by Institutions (%) | 27.30% |
| Float | 27.93M |
Valuation Ratios
The trailing PE ratio is 64.84 and the forward PE ratio is 40.71.
| PE Ratio | 64.84 |
| Forward PE | 40.71 |
| PS Ratio | 10.10 |
| Forward PS | 7.95 |
| PB Ratio | 7.49 |
| P/TBV Ratio | 7.49 |
| P/FCF Ratio | 49.03 |
| P/OCF Ratio | 41.61 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 77.34, with an EV/FCF ratio of 44.18.
| EV / Earnings | 58.42 |
| EV / Sales | 9.10 |
| EV / EBITDA | 77.34 |
| EV / EBIT | 88.96 |
| EV / FCF | 44.18 |
Financial Position
The company has a current ratio of 3.34, with a Debt / Equity ratio of 0.09.
| Current Ratio | 3.34 |
| Quick Ratio | 2.81 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.91 |
| Debt / FCF | 0.58 |
| Interest Coverage | 4.44 |
Financial Efficiency
Return on equity (ROE) is 12.55% and return on invested capital (ROIC) is 31.47%.
| Return on Equity (ROE) | 12.55% |
| Return on Assets (ROA) | 3.31% |
| Return on Invested Capital (ROIC) | 31.47% |
| Return on Capital Employed (ROCE) | 6.16% |
| Weighted Average Cost of Capital (WACC) | 5.24% |
| Revenue Per Employee | $435,814 |
| Profits Per Employee | $67,891 |
| Employee Count | 129 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 2.34 |
Taxes
In the past 12 months, BrainsWay has paid $98,000 in taxes.
| Income Tax | 98,000 |
| Effective Tax Rate | 1.11% |
Stock Price Statistics
The stock price has increased by +159.27% in the last 52 weeks. The beta is 0.15, so BrainsWay's price volatility has been lower than the market average.
| Beta (5Y) | 0.15 |
| 52-Week Price Change | +159.27% |
| 50-Day Moving Average | 15.33 |
| 200-Day Moving Average | 11.25 |
| Relative Strength Index (RSI) | 41.19 |
| Average Volume (20 Days) | 114,461 |
Short Selling Information
The latest short interest is 134,307, so 0.44% of the outstanding shares have been sold short.
| Short Interest | 134,307 |
| Short Previous Month | 131,877 |
| Short % of Shares Out | 0.44% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.88 |
Income Statement
In the last 12 months, BrainsWay had revenue of $56.22 million and earned $8.76 million in profits. Earnings per share was $0.22.
| Revenue | 56.22M |
| Gross Profit | 42.45M |
| Operating Income | 5.75M |
| Pretax Income | 8.86M |
| Net Income | 8.76M |
| EBITDA | 6.62M |
| EBIT | 5.75M |
| Earnings Per Share (EPS) | $0.22 |
Balance Sheet
The company has $58.64 million in cash and $6.71 million in debt, with a net cash position of $51.93 million or $1.36 per share.
| Cash & Cash Equivalents | 58.64M |
| Total Debt | 6.71M |
| Net Cash | 51.93M |
| Net Cash Per Share | $1.36 |
| Equity (Book Value) | 75.80M |
| Book Value Per Share | 1.99 |
| Working Capital | 55.07M |
Cash Flow
In the last 12 months, operating cash flow was $13.65 million and capital expenditures -$2.07 million, giving a free cash flow of $11.58 million.
| Operating Cash Flow | 13.65M |
| Capital Expenditures | -2.07M |
| Depreciation & Amortization | 864,000 |
| Net Borrowing | -883,000 |
| Free Cash Flow | 11.58M |
| FCF Per Share | $0.30 |
Margins
Gross margin is 75.51%, with operating and profit margins of 10.23% and 15.58%.
| Gross Margin | 75.51% |
| Operating Margin | 10.23% |
| Pretax Margin | 15.75% |
| Profit Margin | 15.58% |
| EBITDA Margin | 11.77% |
| EBIT Margin | 10.23% |
| FCF Margin | 20.60% |
Dividends & Yields
BrainsWay does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.85% |
| Shareholder Yield | -3.85% |
| Earnings Yield | 1.54% |
| FCF Yield | 2.04% |
Analyst Forecast
The average price target for BrainsWay is $16.67, which is 17.98% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $16.67 |
| Price Target Difference | 17.98% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 27.68% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 4, 2026. It was a forward split with a ratio of 2:1.
| Last Split Date | Mar 4, 2026 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
BrainsWay has an Altman Z-Score of 4.74 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.74 |
| Piotroski F-Score | 5 |